Key result
High-risk arrhythmogenic variants linked to ~9.2-fold higher odds of LGE in DCM.
Why the study?
The specific genotype-phenotype associations underlying the heterogeneity of dilated cardiomyopathy remain incompletely clear.
Observational (n=90)
High-risk arrhythmogenic variants in dilated cardiomyopathy are associated with extensive myocardial injury and fibrosis on CMR, suggesting tissue characterization can aid in identifying genotype-associated phenotypic differences.
Answers are grounded in this paper and cite their sources.
CMR tissue characterization may aid identification of high-risk variants in dilated cardiomyopathy; leaves open prospective validation for risk stratification.
BACKGROUND: Dilated cardiomyopathy (DCM) exhibits substantial genotypic heterogeneity, paralleled by diverse cardiac magnetic resonance (CMR) phenotypes and clinical presentations. However, the specific genotype-phenotype associations underlying this heterogeneity remain incompletely clear. METHODS: Ninety DCM patients were prospectively enrolled and stratified into three subtypes: high-risk arrhythmogenic variant carriers (HRAv, n = 30), TTN truncating variant carriers (TTNtv, n = 30), and genotype-negative patients (GN, n = 30). High-risk arrhythmogenic variants were identified as DSP, FLNC, LMNA, and PLN variants. Comprehensive CMR parameter comparisons and logistic regression analyses were performed to identify the associations between genotypes and CMR features. RESULTS: Among 90 participants (mean age, 46 years; 54 men), no significant differences were observed in ventricular volumes, systolic functions or LV strain among subtypes. HRAv patients presented with a higher prevalence of LGE (83%) compared with TTNtv (13%) and GN (40%) (p < 0.001), with typical linear midwall, ring-like, and subepicardial patterns. Global native T1 mapping(1379 vs. 1329 vs. 1335 ms, p = 0.037), T2 mapping (46.3 vs. 44.1 vs. 42.8 ms, p < 0.001), and extracellular volume (ECV)(35.8 vs. 31.3 vs. 30.5%, p < 0.001) were significantly elevated in HRAv compared with TTNtv and GN. In Firth penalized logistic regression models, higher global T2 (odds ratio[OR] = 1.22, 95%CI: 1.06-1.43, p = 0.004), higher global ECV(OR = 1.45, 95%CI: 1.17-1.86, p < 0.001), and LGE presence(OR = 9.22, 95%CI: 3.26-29.81, p < 0.001) were independently associated with HRAv status when separately added to the baseline model. CONCLUSION: Compared with TTNtv and genotype-negative DCM, HRAv is characterized by a distinct CMR tissue phenotype marked by more extensive myocardial injury and fibrosis, despite similar ventricular remodeling and systolic impairment. These findings suggest that CMR tissue characterization may help identify genotype-associated phenotypic differences in DCM.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) conducted an observational in Dilated cardiomyopathy (n=90). High-risk arrhythmogenic variants (HRAv) vs. TTN truncating variant carriers (TTNtv) and genotype-negative (GN) patients was evaluated on Presence of late gadolinium enhancement (LGE) (OR 9.22, 95% CI 3.26-29.81, p=<0.001). In dilated cardiomyopathy, high-risk arrhythmogenic variants were strongly associated with late gadolinium enhancement compared with other genotypes.
Synapse has enriched 10 related papers. Consider them for comparative context: